ITUS CORPORATION

12100 Wilshire Boulevard, Suite 1275

Los Angeles, CA  90025

March 24, 2017

VIA EDGAR

Securities and Exchange Commission

100 F. Street, NE

Washington, DC 20549

 

Re:   ITUS Corporation

Request for Withdrawal Pursuant to Rule 477 of Registration Statement on Form S-1 (File No. 333-215799)

Ladies and Gentleman:

On behalf of ITUS Corporation ( we, us, our, or the Company ), we hereby submit this letter to notify the Securities and Exchange Commission (the SEC ) of our withdrawal of our Registration Statement on Form S-1 (File No. 333-215799) (the Registration Statement ) in accordance with the instructions of the staff of the Securities and Exchange Commission. No securities were sold under the Registration Statement. Pursuant to Rule 477 under the Securities Act of 1933, as amended, the Company hereby withdraws the Registration Statement.

Thank you for your assistance with this matter. If you have any questions or comments concerning this request, please call our attorney David Selengut of Ellenoff Grossman & Schole LLP at (212) 370-1300.

 


 

Sincerely,

 

/s/ Robert A. Berman

Robert A. Berman

President and Chief Executive Officer





Anixa Biosciences (NASDAQ:ANIX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Anixa Biosciences Charts.
Anixa Biosciences (NASDAQ:ANIX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Anixa Biosciences Charts.